RxDoctor Payments DataLook up a doctor →

Behzad Molavi, MD

Interventional Cardiology · Brighton, CONPI 1306936885

Payments from drug & device makers

$85,467in general payments, 2019–2025

Across 1,039 payments — averaging $82.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$38K
  • Medtronic$14K
  • Angiodynamics, Inc.$4K
  • Abbott$3K
  • Boston Scientific$2K
  • Cvrx, Inc.$2K
  • plus $21K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bard Peripheral Vascular, Inc.27$37,864
Medtronic(2 entities)166$14,116
Angiodynamics, Inc.11$4,476
Abbott47$3,069
Boston Scientific50$2,321
Cvrx, Inc.20$1,897
Biotronik Inc.24$1,828
Actelion Pharmaceuticals US, Inc.88$1,766
Shockwave Medical, Inc18$1,566
Philips North America LLC33$1,205
Johnson & Johnson61$988
Cardiovascular Systems Inc.12$867
E.r. Squibb & Sons, L.L.C.37$839
Inari Medical, Inc.24$800
Penumbra, Inc.7$799
Novartis36$778
Impulse Dynamics (USA) Inc.9$774
Bayer33$692
Amgen31$676
AstraZeneca33$651
Heartflow, Inc.23$568
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)23$531
Sanofi-aventis U.S. LLC23$524
W. L. Gore & Associates, Inc.7$492
Kestra Medical Technology Services, Inc.15$466
Boehringer Ingelheim21$455
Novo Nordisk20$368
Pfizer16$357
Abiomed8$327
Endologix LLC4$269
Alnylam Pharmaceuticals Inc.9$262
Cagent Vascular Inc3$243
Terumo Medical Corporation2$214
Merck10$186
Esperion Therapeutics, Inc.10$176
Tactile Systems Technology Inc8$168
Smith+Nephew1$141
United Therapeutics Corporation5$130
ZOLL Respicardia, Inc.1$129
Amarin Pharma, Inc.6$124
Cardinal Health 200 LLC2$123
Cardiva Medical, Inc.3$117
Siemens Medical Solutions USA, Inc.1$91
Kiniksa Pharmaceuticals International, PLC4$78
Scpharmaceuticals Inc.4$70
Preventice Services, LLC2$67
Regeneron Healthcare Solutions, Inc.2$66
Daiichi Sankyo Inc.4$64
Veryan Medical Incorporated1$54
Venclose Inc.4$52
Kaneka Medical America LLC1$41
Arbor Pharmaceuticals, Inc.2$36
Lundbeck LLC2$36
Kiniksa Pharmaceuticals, Ltd.2$35
Ionis Pharmaceuticals, Inc.1$34
Lexicon Pharmaceuticals, Inc.2$30
Bridgebio Pharma, Inc.1$28
Ossur Americas, Inc.1$26
Asahi Intecc USA, Inc.1$25
Inspire Medical Systems, Inc.1$25

How this compares

$85,467 in reported general payments places this provider in the 70th percentile of 111 interventional cardiology providers in Colorado.

See all interventional cardiology providers in Colorado

Medicare billing

Part B allowed, 2024
$362,440
Medicare patients
428
Services billed
2,916

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Brighton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →